UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

Urologic oncology, 2015-02, Vol.33 (2), p.71.e1-71.e9

2015

Volltextzugriff (PDF)

Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy

European urology, 2009-02, Vol.55 (2), p.261-270

2009

Volltextzugriff (PDF)

Does the inclusion of non-index lesions at biopsy improve our ability to predict adverse pathologic outcomes at radical prostatectomy? Implications for targeted plus systematic biopsy schemes

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e877-e878

2017

Volltextzugriff (PDF)

1045 A new proposal for t1, high grade bladder cancer micro-staging definition

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e1045-e1045a

2015

Volltextzugriff (PDF)

744 The number of cores taken at first negative biopsy does not affect the cancer detection rate at saturation repeat biopsy in patients with persistent suspicion of prostate cancer

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e744-e744

2014

Volltextzugriff (PDF)

909 Clinical cut-offs of isoform [-2]proPSA (p2PSA) derivatives, namely %p2PSA and PHI (Prostate Health Index) for guiding biopsy decision in Caucasian population

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e909-e909a

2012

Volltextzugriff (PDF)

122 A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e122-e122

2012

Volltextzugriff (PDF)

1012 Evaluation of lymph node recurrent prostate cancer with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: Validation by histological analysis

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e1012-e1012a

2012

Volltextzugriff (PDF)

278 Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e278-e278

2012

Volltextzugriff (PDF)

534 SINGLE MINUTE FOCUS OF PROSTATE CANCER ON NEEDLE BIOPSY: PREDICTING FACTORS FOR A LOCALLY ADVANCED PROSTATE CANCER ON RADICAL PROSTATECTOMY AND DEVELOPMENT OF A NOMOGRAM

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.178-178

2011

Volltextzugriff (PDF)

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.148-148

2011

Volltextzugriff (PDF)

1079 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.332-332

2011

Volltextzugriff (PDF)

559 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT AFFECT THE RATE OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RETROPUBIC RADICAL PROSTATECTOMY

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.184-185

2011

Volltextzugriff (PDF)

23 A PROPOSAL FOR THE IDEAL SAMPLING SCHEME IN PROSTATE REPEATED BIOPSIES: A RECURSIVE PARTITIONING ANALYSIS BASED ON 24-CORE SYSTEMATIC BIOPSY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.41-41

2010

Volltextzugriff (PDF)

682 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.224-224

2010

Volltextzugriff (PDF)

449 DIFFERENT SURVIVAL OF HISTOLOGIC SUBTYPE IN PATIENTS WITH RENAL RENAL CELL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.161-162

2010

Volltextzugriff (PDF)

32 PREOPERATIVE CIRCULATING ESTRADIOL, TESTOSTERONE AND SEX HORMONE BINDING GLOBULIN ARE NOT PREDICTORS OF POSITIVE SURGICAL MARGINS AT OPEN RADICAL PROSTATECTOMY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.44-44

2010

Volltextzugriff (PDF)

835 HIGH-GRADE PIN DIAGNOSIS: THE IMPACT OF THE NUMBER OF BIOPSY CORES AT INITIAL SAMPLING ON CANCER DETECTION AFTER A SATURATION RE-BIOPSY

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.329-329

2009

Volltextzugriff (PDF)

FACTORS PREDICTING DISEASE FREE SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION IN THE PSA ERA: ROLE OF ADJUVANT RADIOTHERAPY

European urology supplements : official journal of the European Association of Urology, 2008, Vol.7 (3), p.207-207

2008

Volltextzugriff (PDF)

DEVELOPMENT AND INTERNAL VALIDATION OF A NOVEL NOMOGRAM PREDICTING BLADDER CANCER SPECIFIC SURVIVAL OF PATIENTS WITH PT0 DISEASE FOLLOWING RADICAL CYSTECTOMY. RESULTS FROM A TWO INSTITUTION SERIES

European urology supplements : official journal of the European Association of Urology, 2008, Vol.7 (3), p.78-78

2008

Volltextzugriff (PDF)

698 INITIAL EXTENDED TRANSRECTAL PROSTATIC BIOPSY: DO 18 CORES DETECT MORE PROSTATIC CANCERS THAN 12 CORES?

European urology supplements : official journal of the European Association of Urology, 2007, Vol.6 (2), p.197-197

2007

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaUrology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Kollektion

IngentaConnect Journals
(21)
Ingenta
(21)
Elsevier ScienceDirect Journals Collection
(21)
MEDLINE
(2)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

Does the inclusion of non-index lesions at biopsy improve our ability to predict adverse pathologic outcomes at radical prostatectomy? Implications for targeted plus systematic biopsy schemes

1045 A new proposal for t1, high grade bladder cancer micro-staging definition

744 The number of cores taken at first negative biopsy does not affect the cancer detection rate at saturation repeat biopsy in patients with persistent suspicion of prostate cancer

909 Clinical cut-offs of isoform [-2]proPSA (p2PSA) derivatives, namely %p2PSA and PHI (Prostate Health Index) for guiding biopsy decision in Caucasian population

122 A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis

1012 Evaluation of lymph node recurrent prostate cancer with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: Validation by histological analysis

278 Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa

534 SINGLE MINUTE FOCUS OF PROSTATE CANCER ON NEEDLE BIOPSY: PREDICTING FACTORS FOR A LOCALLY ADVANCED PROSTATE CANCER ON RADICAL PROSTATECTOMY AND DEVELOPMENT OF A NOMOGRAM

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

1079 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES

559 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT AFFECT THE RATE OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RETROPUBIC RADICAL PROSTATECTOMY

23 A PROPOSAL FOR THE IDEAL SAMPLING SCHEME IN PROSTATE REPEATED BIOPSIES: A RECURSIVE PARTITIONING ANALYSIS BASED ON 24-CORE SYSTEMATIC BIOPSY

682 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS

449 DIFFERENT SURVIVAL OF HISTOLOGIC SUBTYPE IN PATIENTS WITH RENAL RENAL CELL CARCINOMA

32 PREOPERATIVE CIRCULATING ESTRADIOL, TESTOSTERONE AND SEX HORMONE BINDING GLOBULIN ARE NOT PREDICTORS OF POSITIVE SURGICAL MARGINS AT OPEN RADICAL PROSTATECTOMY

835 HIGH-GRADE PIN DIAGNOSIS: THE IMPACT OF THE NUMBER OF BIOPSY CORES AT INITIAL SAMPLING ON CANCER DETECTION AFTER A SATURATION RE-BIOPSY

FACTORS PREDICTING DISEASE FREE SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION IN THE PSA ERA: ROLE OF ADJUVANT RADIOTHERAPY

DEVELOPMENT AND INTERNAL VALIDATION OF A NOVEL NOMOGRAM PREDICTING BLADDER CANCER SPECIFIC SURVIVAL OF PATIENTS WITH PT0 DISEASE FOLLOWING RADICAL CYSTECTOMY. RESULTS FROM A TWO INSTITUTION SERIES

698 INITIAL EXTENDED TRANSRECTAL PROSTATIC BIOPSY: DO 18 CORES DETECT MORE PROSTATIC CANCERS THAN 12 CORES?

Aktive Filter

Suchergebnisse filtern